Friedreich's Ataxia Research Alliance

• United States

Sources: ror.org

• Founded

  1 Jan 1998

Sources: ror.org

• NCT05168774

  Collaborator, Phase 1/2, Completed, 20 people, 23 Dec 2021

• NCT02705547

  Collaborator, Early phase 1, Completed, 12 people, 10 Mar 2016

• NCT01339884

  Collaborator, Phase 1/2, Completed, 27 people, 21 Apr 2011

• NCT00803868

  Collaborator, Phase 2/3, Terminated, 28 people, 8 Dec 2008

• A second-generation "hypoxia in a pill" rescues neurodegenerative phenotypes across distinct mouse models

  N/A, 9 Oct 2026

Sources: api.crossref.org

• Oxygen-limiting drug combination extends lifespan in mice

  Proceedings of the National Academy of Sciences of the United States of America, 9 Oct 2026

• Safety and efficacy of individualised exercise and NAD+ precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trial

  The Lancet. Neurology, 17 Apr 2026